Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
254,691,824
-
Total 13F shares
-
235,652,837
-
Share change
-
+2,669,993
-
Total reported value
-
$106,789,033,467
-
Put/Call ratio
-
76%
-
Price per share
-
$453.36
-
Number of holders
-
1,640
-
Value change
-
+$1,348,256,933
-
Number of buys
-
776
-
Number of sells
-
660
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2025
As of 31 Dec 2025,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,640 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
235,652,837 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Capital International Investors, ALLIANCEBERNSTEIN L.P., and LOOMIS SAYLES & CO L P.
This page lists
1,640
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.